NovaMatrix produces and supplies well-characterized and documented ultrapure, bio-compatible and bio-absorbable biopolymers for use in the pharmaceutical, biotechnology and biomedical industries, including applications such as drug delivery, tissue engineering, cell encapsulation, and medical devices. Our products are ultimately intended to be used in applications which require extremely high and consistent quality, and our production and quality assurance systems are designed to provide such quality.
We manufacture PRONOVATM sodium alginate and PROTASANTM chitosan salts in Sandvika, Norway in accordance with GMP guidelines; ICH Q7; and ISO standards: ISO 9001:2008, ISO 13485:2003 and ISO 22442:2007. Our Sodium Hyaluronate Pharma Grade is produced by our strategic partner, Kikkoman Biochemifa Company (KBC), formerly Kibun Foodchemifa, in Kamogawa, Japan under GMP guidelines; the Pharmaceutical Affairs Law of Japan, ICH Q7 and ISO standards; ISO 9001:2008 and ISO 14001:2004. Please access our ISO Certificate with this link.
To assist our customers who are developing medical applications, we maintain Drug Master Files with the US FDA for our ultrapure sodium alginates, chitosan salts and bases, and sodium hyaluronate.